Previous Close | 0.1750 |
Open | 0.1850 |
Bid | 0.1750 x 0 |
Ask | 0.1900 x 0 |
Day's Range | 0.1850 - 0.1850 |
52 Week Range | 0.1400 - 0.2800 |
Volume | |
Avg. Volume | 6,343 |
Market Cap | 25.386M |
Beta (5Y Monthly) | 1.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0900 |
Earnings Date | Mar 22, 2024 - Mar 26, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for AMM.TO
VANCOUVER, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) is providing an update regarding its Request for Consultations delivered to the United Mexican States (“Mexico”, see press release dated December 14, 2023), and its listing on the NYSE American stock exchange (see press release of October 25, 2023). Request for Consultations As previously reported, on December 13, 2023, Almaden delivered to Mexico a wri
VANCOUVER, British Columbia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) announces that it has delivered to the United Mexican States (“Mexico”) a Request for Consultations in accordance with the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) relating to an investment dispute with Mexico. Almaden sent the Request for Consultations to Mexico’s General Directorate of Legal Consultancy for Intern
VANCOUVER, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) announces that, further to its press release of April 21, 2023, it has received an extension of its cure deadline from October 19, 2023 to April 19, 2024 (“New Cure Deadline”). As previously announced, Almaden is not in compliance with the continued listing standards of the NYSE American exchange because the Company’s securities have been selling for a l